Production (Stage)
CalciMedica, Inc.
CALC
$1.70
-$0.02-1.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.15% | 2.21% | -2.62% | -3.85% | 19.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.96% | 10.65% | 8.18% | 12.20% | 33.37% |
| Operating Income | -15.96% | -10.65% | -8.18% | -12.20% | -33.37% |
| Income Before Tax | -26.33% | 60.12% | 52.81% | 52.95% | 36.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.33% | 60.12% | 52.81% | 52.95% | 36.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.33% | 60.12% | 52.81% | 52.95% | 36.38% |
| EBIT | -15.96% | -10.65% | -8.18% | -12.20% | -33.37% |
| EBITDA | -16.02% | -10.68% | -8.15% | -12.20% | -33.43% |
| EPS Basic | 41.41% | 95.50% | 93.51% | 96.55% | 97.06% |
| Normalized Basic EPS | 41.41% | 81.65% | 92.69% | 96.36% | 96.97% |
| EPS Diluted | 41.42% | 95.49% | 93.51% | 96.55% | 97.06% |
| Normalized Diluted EPS | 41.41% | 81.64% | 92.69% | 96.36% | 96.97% |
| Average Basic Shares Outstanding | 83.97% | 151.39% | 208.57% | 385.39% | 2,398.90% |
| Average Diluted Shares Outstanding | 81.98% | 153.03% | 210.96% | 389.80% | 2,426.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |